Clinical trial

A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer

NCT04148885

Study summary

ClinicalTrials.gov

A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention nab-paclitaxel Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record carboplatin Normalized identity: carboplatin View linked drug · Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2019-11-01

PhasePHASE1 / PHASE2

Conditions

Castration-resistant Prostate Cancerunresolved

Interventions

nab-paclitaxelDRUG

carboplatinDRUG · verified · RxNorm: carboplatin

Sponsors & collaborators

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04148885 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.